Cargando…

Waning but persistent humoral response 6 months after the third dose of the mRNA BNT162b2 vaccine in hemodialysis and peritoneal dialysis patients

Detalles Bibliográficos
Autores principales: Housset, Pierre, Kubab, Sabah, Pardon, Agathe, Vittoz, Nathalie, Bozman, Dogan-Firat, Hanafi, Latifa, Caudwell, Valérie, Faucon, Anne-Laure
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861617/
https://www.ncbi.nlm.nih.gov/pubmed/35192157
http://dx.doi.org/10.1007/s40620-022-01276-2
_version_ 1784654923710857216
author Housset, Pierre
Kubab, Sabah
Pardon, Agathe
Vittoz, Nathalie
Bozman, Dogan-Firat
Hanafi, Latifa
Caudwell, Valérie
Faucon, Anne-Laure
author_facet Housset, Pierre
Kubab, Sabah
Pardon, Agathe
Vittoz, Nathalie
Bozman, Dogan-Firat
Hanafi, Latifa
Caudwell, Valérie
Faucon, Anne-Laure
author_sort Housset, Pierre
collection PubMed
description
format Online
Article
Text
id pubmed-8861617
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-88616172022-02-22 Waning but persistent humoral response 6 months after the third dose of the mRNA BNT162b2 vaccine in hemodialysis and peritoneal dialysis patients Housset, Pierre Kubab, Sabah Pardon, Agathe Vittoz, Nathalie Bozman, Dogan-Firat Hanafi, Latifa Caudwell, Valérie Faucon, Anne-Laure J Nephrol Research Letter Springer International Publishing 2022-02-22 2022 /pmc/articles/PMC8861617/ /pubmed/35192157 http://dx.doi.org/10.1007/s40620-022-01276-2 Text en © The Author(s) under exclusive licence to Italian Society of Nephrology 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Research Letter
Housset, Pierre
Kubab, Sabah
Pardon, Agathe
Vittoz, Nathalie
Bozman, Dogan-Firat
Hanafi, Latifa
Caudwell, Valérie
Faucon, Anne-Laure
Waning but persistent humoral response 6 months after the third dose of the mRNA BNT162b2 vaccine in hemodialysis and peritoneal dialysis patients
title Waning but persistent humoral response 6 months after the third dose of the mRNA BNT162b2 vaccine in hemodialysis and peritoneal dialysis patients
title_full Waning but persistent humoral response 6 months after the third dose of the mRNA BNT162b2 vaccine in hemodialysis and peritoneal dialysis patients
title_fullStr Waning but persistent humoral response 6 months after the third dose of the mRNA BNT162b2 vaccine in hemodialysis and peritoneal dialysis patients
title_full_unstemmed Waning but persistent humoral response 6 months after the third dose of the mRNA BNT162b2 vaccine in hemodialysis and peritoneal dialysis patients
title_short Waning but persistent humoral response 6 months after the third dose of the mRNA BNT162b2 vaccine in hemodialysis and peritoneal dialysis patients
title_sort waning but persistent humoral response 6 months after the third dose of the mrna bnt162b2 vaccine in hemodialysis and peritoneal dialysis patients
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861617/
https://www.ncbi.nlm.nih.gov/pubmed/35192157
http://dx.doi.org/10.1007/s40620-022-01276-2
work_keys_str_mv AT houssetpierre waningbutpersistenthumoralresponse6monthsafterthethirddoseofthemrnabnt162b2vaccineinhemodialysisandperitonealdialysispatients
AT kubabsabah waningbutpersistenthumoralresponse6monthsafterthethirddoseofthemrnabnt162b2vaccineinhemodialysisandperitonealdialysispatients
AT pardonagathe waningbutpersistenthumoralresponse6monthsafterthethirddoseofthemrnabnt162b2vaccineinhemodialysisandperitonealdialysispatients
AT vittoznathalie waningbutpersistenthumoralresponse6monthsafterthethirddoseofthemrnabnt162b2vaccineinhemodialysisandperitonealdialysispatients
AT bozmandoganfirat waningbutpersistenthumoralresponse6monthsafterthethirddoseofthemrnabnt162b2vaccineinhemodialysisandperitonealdialysispatients
AT hanafilatifa waningbutpersistenthumoralresponse6monthsafterthethirddoseofthemrnabnt162b2vaccineinhemodialysisandperitonealdialysispatients
AT caudwellvalerie waningbutpersistenthumoralresponse6monthsafterthethirddoseofthemrnabnt162b2vaccineinhemodialysisandperitonealdialysispatients
AT fauconannelaure waningbutpersistenthumoralresponse6monthsafterthethirddoseofthemrnabnt162b2vaccineinhemodialysisandperitonealdialysispatients